Blood Flow Mismatch in Pancreatic Cancers Concord NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

John David Turner, MD
(704) 783-3369
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Emory Univ Sch Of Med, Atlanta Ga 30322
Graduation Year: 1992

Data Provided by:
Christine Frances Piller
(704) 783-1542
920 Church St N
Concord, NC
Specialty
Hematology

Data Provided by:
Karis H Kremers, MD
(704) 783-1370
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Ms Sch Of Med, Jackson Ms 39216
Graduation Year: 1980

Data Provided by:
James Hugh North
(704) 786-1108
200 Medical Park Dr
Concord, NC
Specialty
Surgical Oncology

Data Provided by:
William Robert Mitchell
(704) 593-0244
101 W. T. Harris Blvd
Charlotte, NC
Specialty
Hematology / Oncology

Data Provided by:
Thomas Albert Steffens, MD
(704) 783-1370
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1982

Data Provided by:
Richard F Williams, MD
(704) 783-3000
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 72205
Graduation Year: 1988

Data Provided by:
James G Wall
(704) 783-1370
100 Medical Park Dr
Concord, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
George Philip Sartiano, MD
Kannapolis, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1960

Data Provided by:
Warden L Woodard
(704) 863-6160
101 E Wt Harris Blvd
Charlotte, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com